AbbVie (ABBV) Change in Taxes (2019 - 2026)

AbbVie has disclosed Change in Taxes across 8 years of filings, most recently posting -$81.0 million for Q1 2026.

• In Q1 2026, Change in Taxes fell 121.43% year-over-year to -$81.0 million; the TTM figure through Mar 2026 stood at -$1.2 billion (up 61.94% YoY), while the FY2025 annual figure was -$762.0 million, up 76.25% from the prior year.
• Change in Taxes retreated to -$81.0 million in Q1 2026, from $646.0 million in the prior quarter.
• Over the last five years, Change in Taxes for ABBV reached as high as $646.0 million in Q4 2025 and fell as low as -$1.8 billion in Q2 2024.
• The 5-year median for Change in Taxes is $51.0 million (2024), against an average of -$235.1 million.
• Annual changes were most pronounced in 2022 — Change in Taxes soared 545.45% — and 2025, when it slumped 905.88%.
• A 5-year view of Change in Taxes shows it stood at $358.0 million in 2022, then advanced by 14.8% to $411.0 million in 2023, then slumped by 538.69% to -$1.8 billion in 2024, then soared by 135.83% to $646.0 million in 2025, then plunged by 112.54% to -$81.0 million in 2026.
• According to Business Quant data, Change in Taxes over the past three periods registered -$81.0 million, $646.0 million, and -$411.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.